PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Antimicrob Agents Chemother. 1995 August; 39(8): 1885–1887.
PMCID: PMC162848

Liposomal amphotericin B therapy of murine histoplasmosis.

Abstract

Liposomal amphotericin B (AmBisome) was compared with amphotericin B deoxycholate for the treatment of disseminated murine histoplasmosis. Liposomal amphotericin B was well tolerated and, milligram for milligram, was as potent as amphotericin B deoxycholate.

Full Text

The Full Text of this article is available as a PDF (184K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allendoerfer R, Magee DM, Deepe GS, Jr, Graybill JR. Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun. 1993 Feb;61(2):714–718. [PMC free article] [PubMed]
  • Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665–668. [PubMed]
  • Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: delivery systems. Antimicrob Agents Chemother. 1990 Mar;34(3):381–384. [PMC free article] [PubMed]
  • Dismukes WE, Stamm AM, Graybill JR, Craven PC, Stevens DA, Stiller RL, Sarosi GA, Medoff G, Gregg CR, Gallis HA, et al. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med. 1983 Jan;98(1):13–20. [PubMed]
  • Gondal JA, Swartz RP, Rahman A. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother. 1989 Sep;33(9):1544–1548. [PMC free article] [PubMed]
  • Karyotakis NC, Anaissie EJ. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice. Antimicrob Agents Chemother. 1994 Nov;38(11):2660–2662. [PMC free article] [PubMed]
  • Lopez-Berestein G. Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother. 1987 May;31(5):675–678. [PMC free article] [PubMed]
  • Meunier F, Prentice HG, Ringdén O. Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J Antimicrob Chemother. 1991 Oct;28 (Suppl B):83–91. [PubMed]
  • Norris S, Wheat J, McKinsey D, Lancaster D, Katz B, Black J, Driks M, Baker R, Israel K, Traeger D, et al. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med. 1994 Jun;96(6):504–508. [PubMed]
  • Pahls S, Schaffner A. Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. J Infect Dis. 1994 May;169(5):1057–1061. [PubMed]
  • Schmitt HJ. New methods of delivery of amphotericin B. Clin Infect Dis. 1993 Nov;17 (Suppl 2):S501–S506. [PubMed]
  • Sharkey-Mathis PK, Velez J, Fetchick R, Graybill JR. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole. J Acquir Immune Defic Syndr. 1993 Jul;6(7):809–819. [PubMed]
  • McBride M, Linney M, Claydon EJ, Weber J. Visceral leishmaniasis following treatment with liposomal amphotericin B. Clin Infect Dis. 1994 Aug;19(2):362–362. [PubMed]
  • Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, Pappagianis D, Stevens DA. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis. 1992 Jan;14(1):165–174. [PubMed]
  • Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990 Nov;69(6):361–374. [PubMed]
  • Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1993 Apr 15;118(8):610–616. [PubMed]
  • Williams DM, Graybill JR, Drutz DJ. Adoptive transfer of immunity to Histoplasma capsulatum in athymic nude mice. Sabouraudia. 1981 Mar;19(1):39–48. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)